Evidence map›Paper›PMID 37708139›Full record

ArticlePLoS biology2023

The human fungal pathogen Aspergillus fumigatus can produce the highest known number of meiotic crossovers.

Ben Auxier, Alfons J M Debets, Felicia Adelina Stanford, Johanna Rhodes, Frank M Becker, Francisca Reyes Marquez, Reindert Nijland, Paul S Dyer, Matthew C Fisher, Joost van den Heuvel and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Accelerated mutator phenotype in a clinicalEmerging microbes & infections · 2026
    Article
  2. Temperature duringbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Structure and function of the synaptonemal complex.The Journal of cell biology · 2026
    Review
  5. Genotype-Phenotype Relationships in Azole-ResistantJournal of fungi (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pan-azole- and multi-fungicide-resistantApplied and environmental microbiology · 2024
    Article
  18. Emerging Antifungal Resistance in Fungal Pathogens.Current clinical microbiology reports · 2024
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ben AuxierLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.
Alfons J M DebetsLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.
Felicia Adelina StanfordSchool of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Johanna RhodesMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Frank M BeckerLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.
Francisca Reyes MarquezLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.
Reindert NijlandMarine Animal Ecology, Wageningen University, Wageningen, the Netherlands.
Paul S DyerSchool of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Matthew C FisherMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Joost van den HeuvelLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.
Eveline SneldersLaboratory of Genetics, Wageningen University; Wageningen, the Netherlands.ORCID 0000-0002-7868-7928
Wageningen University & Research · NLImperial College London · GBUniversity of Nottingham · GB

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/X020258/1Wellcome TrustWellcome Trust 219551/Z/19/Z
6 · The paper itself

Abstract

Sexual reproduction involving meiosis is essential in most eukaryotes. This produces offspring with novel genotypes, both by segregation of parental chromosomes as well as crossovers between homologous chromosomes. A sexual cycle for the opportunistic human pathogenic fungus Aspergillus fumigatus is known, but the genetic consequences of meiosis have remained unknown. Among other Aspergilli, it is known that A. flavus has a moderately high recombination rate with an average of 4.2 crossovers per chromosome pair, whereas A. nidulans has in contrast a higher rate with 9.3 crossovers per chromosome pair. Here, we show in a cross between A. fumigatus strains that they produce an average of 29.9 crossovers per chromosome pair and large variation in total map length across additional strain crosses. This rate of crossovers per chromosome is more than twice that seen for any known organism, which we discuss in relation to other genetic model systems. We validate this high rate of crossovers through mapping of resistance to the laboratory antifungal acriflavine by using standing variation in an undescribed ABC efflux transporter. We then demonstrate that this rate of crossovers is sufficient to produce one of the common multidrug resistant haplotypes found in the cyp51A gene (TR34/L98H) in crosses among parents harboring either of 2 nearby genetic variants, possibly explaining the early spread of such haplotypes. Our results suggest that genomic studies in this species should reassess common assumptions about linkage between genetic regions. The finding of an unparalleled crossover rate in A. fumigatus provides opportunities to understand why these rates are not generally higher in other eukaryotes.

Indexed as

Aspergillus fumigatusATP-Binding Cassette TransportersAntifungal AgentsBiological TransportEukaryotaHumansMeiosisAntifungal AgentsATP-Binding Cassette Transporters

Identifiers

PMID37708139
PMCPMC10501685
OpenAlexW4386738334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.